About Us

About Us

Hong Kong Valve started 3 years ago by the heart team of Queen Mary Hospital, Hong Kong.
This is a focused meeting about heart valve diseases and the state of the art treatment. Key of the modern treatment of heart valve is team approach. Bringing the zenith skills of surgeon and interventionist together create a whole new perspective of treatment option. That’s why Hong Kong Valve balance the content between both sides and cover the knowledge from basic science to practical skills.
Every year we have local, regional and overseas experts come and share their experience and knowledge. Through live cases, lectures, workshops and case forum we hope everyone can enjoy a fruitful and wonderful learning weekend.
Welcome and see you all!

  • Dr. Daniel Tai-leung CHAN

    Dr. Daniel Tai-leung Chan is a consultant surgeon at the Departmentof Cardiothoracic Surgery of Queen Mary Hospital, Hong Kong. Afterobtaining a Fellowship in Cardiothoracic Surgery of the College of Surgeons of Edinburgh in 2009, he pursued advanced training in cardiac surgery especially minimally invasive approaches in East Carolina University, USA, under the guidance of Prof. Randolph Chitwood. He performs a full range of cardiac surgeries from coronary and valvular surgeries to heart transplantations, while his special clinical and research interests are in minimally invasive cardiac surgery and transcatheter procedures.

  • Dr. Simon Cheung-chi LAM

    Dr. Simon Lam graduated from the Li Ka Shing Faculty of Medicine, University of Hong Kong in 2003. He is an interventional cardiologist from the Division of Cardiology, Department of Medicine, Queen Mary Hospital, Hong Kong. He received his post-fellowship training in Structural and Congenital Heart Intervention in CardioVasculares Centrum Frankfurt, Germany under Prof. Horst Sievert in 2012-2013. His special interests include transcatheter aortic valve implantation, left atrial appendage occlusion, MitraClip, closure of septal defects and paravalvular leaks, renal denervation, complex PCI and intracoronary optical coherence tomography. He is a physician proctor of structural heart intervention procedures, including Edwards SAPIEN Transcatheter Heart Valve and AMULET Left Atrial Appendage Occluder Device.

  • Prof. David Chung-wah SIU

    Prof. David Siu currently works as a Clinical Professor in the Department of Medicine at the University of Hong Kong. He obtained his medical degree (M.B., B.S.) in 1997, completed his cardiology training in Queen Mary Hospital in 2004 and obtained the degree of Doctor of Medicine (M.D. with Sir Patrick Manson Gold Medal) in 2010 at the University of Hong Kong. In the quest to improve treatment for patients with heart disease, he pursued study in Traditional Chinese Medicine concurrently at the Hong Kong Baptist University and Hubei College of Traditional Chinese Medicine, leading to the award of a Master’s degree in Traditional Chinese Medicine in 2005. Realizing the limitations of current clinical treatment for heart disease, he recognized the potential of stem cell therapy. He left his comfort zone of being a clinical cardiologist to take up the prestigious Croucher Foundation Research Fellowship, enabling him to further his research career in the area of stem cell research at the University of California, Davis, USA from 2006-2007. In 2008, Prof. Siu returned to the University of Hong Kong and commenced his academic career. He is currently a Clinical Professor in the Department of Medicine, Li Ka Shing Faculty of Medicine, the University of Hong Kong. His current research interests focus on inheritable cardiac diseases, atrial fibrillation, heart failure, as well as stem cell research for regenerative medicine. Notably, his laboratory is one of the first three laboratories worldwide to generate human induced pluripotent stem cells using an animal-product free protocol. To date, Prof. Siu has published a total of 150 peer-reviewed articles in international journals such as The Lancet, Journal of the American Medical Association, Archive of Internal Medicine, Circulation, Journal of American College of Cardiology, Blood, Stem cell, Diabetes Care, Journal of Metabolism and Clinical Endocrinology, and has contributed 12 book chapters in Cardiology and Stem Cell Biology. Being an avid member of the cardiology scientific community, Prof. Siu actively supports the continued education and sharing of expertise through both local and international conferences. He recently chaired the Hong Kong Medical Forum in May 2018 and is pivotal in the organization of Hong Kong Valve 2018.